Selected research
Industry Research
Endostatin Protein Industry Research Report 2026
Market perspective
The global Endostatin Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Endostatin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Endostatin Protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Endostatin Protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Endostatin Protein include Hengrui Pharma, ZYBio, Sigma-Aldrich, R&D Systems, Prospec, PeproTech, Novus Biologicals, MyBioSource and MedChem Express, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Endostatin Protein market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Endostatin Protein Market by Company
Hengrui Pharma
ZYBio
Sigma-Aldrich
R&D Systems
Prospec
PeproTech
Novus Biologicals
MyBioSource
MedChem Express
Innovative Research
Denovo Biopharma
BioLegend
Endostatin Protein Segment by Type
Natural Endostatin
Recombinant Endostatin
Endostatin Protein Segment by Application
Medical
Pharmaceuticals
Endostatin Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endostatin Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endostatin Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endostatin Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Endostatin Protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Endostatin Protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Endostatin Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Natural Endostatin
- Recombinant Endostatin
Applications
- Medical
- Pharmaceuticals
Companies covered
- Hengrui Pharma
- ZYBio
- Sigma-Aldrich
- R&D Systems
- Prospec
- PeproTech
- Novus Biologicals
- MyBioSource
- MedChem Express
- Innovative Research
- Denovo Biopharma
- BioLegend
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Endostatin Protein Market Size (2021-2032)
- 2.2.2 Global Endostatin Protein Sales (2021-2032)
- 2.2.3 Global Endostatin Protein Market Average Price (2021-2032)
- 2.3 Endostatin Protein by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Natural Endostatin
- 2.3.3 Recombinant Endostatin
- 2.4 Endostatin Protein by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical
- 2.4.3 Pharmaceuticals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Endostatin Protein Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Endostatin Protein Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Endostatin Protein Revenue of Manufacturers (2021-2026)
- 3.4 Global Endostatin Protein Average Price by Manufacturers (2021-2026)
- 3.5 Global Endostatin Protein Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Endostatin Protein, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Endostatin Protein, Product Type & Application
- 3.8 Global Manufacturers of Endostatin Protein, Established Date
- 3.9 Global Endostatin Protein Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hengrui Pharma
- 4.1.1 Hengrui Pharma Company Information
- 4.1.2 Hengrui Pharma Business Overview
- 4.1.3 Hengrui Pharma Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hengrui Pharma Endostatin Protein Product Portfolio
- 4.1.5 Hengrui Pharma Recent Developments
- 4.2 ZYBio
- 4.2.1 ZYBio Company Information
- 4.2.2 ZYBio Business Overview
- 4.2.3 ZYBio Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 ZYBio Endostatin Protein Product Portfolio
- 4.2.5 ZYBio Recent Developments
- 4.3 Sigma-Aldrich
- 4.3.1 Sigma-Aldrich Company Information
- 4.3.2 Sigma-Aldrich Business Overview
- 4.3.3 Sigma-Aldrich Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sigma-Aldrich Endostatin Protein Product Portfolio
- 4.3.5 Sigma-Aldrich Recent Developments
- 4.4 R&D Systems
- 4.4.1 R&D Systems Company Information
- 4.4.2 R&D Systems Business Overview
- 4.4.3 R&D Systems Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 R&D Systems Endostatin Protein Product Portfolio
- 4.4.5 R&D Systems Recent Developments
- 4.5 Prospec
- 4.5.1 Prospec Company Information
- 4.5.2 Prospec Business Overview
- 4.5.3 Prospec Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Prospec Endostatin Protein Product Portfolio
- 4.5.5 Prospec Recent Developments
- 4.6 PeproTech
- 4.6.1 PeproTech Company Information
- 4.6.2 PeproTech Business Overview
- 4.6.3 PeproTech Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PeproTech Endostatin Protein Product Portfolio
- 4.6.5 PeproTech Recent Developments
- 4.7 Novus Biologicals
- 4.7.1 Novus Biologicals Company Information
- 4.7.2 Novus Biologicals Business Overview
- 4.7.3 Novus Biologicals Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novus Biologicals Endostatin Protein Product Portfolio
- 4.7.5 Novus Biologicals Recent Developments
- 4.8 MyBioSource
- 4.8.1 MyBioSource Company Information
- 4.8.2 MyBioSource Business Overview
- 4.8.3 MyBioSource Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MyBioSource Endostatin Protein Product Portfolio
- 4.8.5 MyBioSource Recent Developments
- 4.9 MedChem Express
- 4.9.1 MedChem Express Company Information
- 4.9.2 MedChem Express Business Overview
- 4.9.3 MedChem Express Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 MedChem Express Endostatin Protein Product Portfolio
- 4.9.5 MedChem Express Recent Developments
- 4.10 Innovative Research
- 4.10.1 Innovative Research Company Information
- 4.10.2 Innovative Research Business Overview
- 4.10.3 Innovative Research Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Innovative Research Endostatin Protein Product Portfolio
- 4.10.5 Innovative Research Recent Developments
- 4.11 Denovo Biopharma
- 4.11.1 Denovo Biopharma Company Information
- 4.11.2 Denovo Biopharma Business Overview
- 4.11.3 Denovo Biopharma Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Denovo Biopharma Endostatin Protein Product Portfolio
- 4.11.5 Denovo Biopharma Recent Developments
- 4.12 BioLegend
- 4.12.1 BioLegend Company Information
- 4.12.2 BioLegend Business Overview
- 4.12.3 BioLegend Endostatin Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BioLegend Endostatin Protein Product Portfolio
- 4.12.5 BioLegend Recent Developments
5 Global Endostatin Protein Market Scenario by Region
- 5.1 Global Endostatin Protein Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Endostatin Protein Sales by Region: 2021-2032
- 5.2.1 Global Endostatin Protein Sales by Region: 2021-2026
- 5.2.2 Global Endostatin Protein Sales by Region: 2027-2032
- 5.3 Global Endostatin Protein Revenue by Region: 2021-2032
- 5.3.1 Global Endostatin Protein Revenue by Region: 2021-2026
- 5.3.2 Global Endostatin Protein Revenue by Region: 2027-2032
- 5.4 North America Endostatin Protein Market Facts & Figures by Country
- 5.4.1 North America Endostatin Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Endostatin Protein Sales by Country (2021-2032)
- 5.4.3 North America Endostatin Protein Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Endostatin Protein Market Facts & Figures by Country
- 5.5.1 Europe Endostatin Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Endostatin Protein Sales by Country (2021-2032)
- 5.5.3 Europe Endostatin Protein Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Endostatin Protein Market Facts & Figures by Country
- 5.6.1 Asia Pacific Endostatin Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Endostatin Protein Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Endostatin Protein Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Endostatin Protein Market Facts & Figures by Country
- 5.7.1 South America Endostatin Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Endostatin Protein Sales by Country (2021-2032)
- 5.7.3 South America Endostatin Protein Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Endostatin Protein Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Endostatin Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Endostatin Protein Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Endostatin Protein Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Endostatin Protein Sales by Type (2021-2032)
- 6.1.1 Global Endostatin Protein Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Endostatin Protein Sales Market Share by Type (2021-2032)
- 6.2 Global Endostatin Protein Revenue by Type (2021-2032)
- 6.2.1 Global Endostatin Protein Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Endostatin Protein Revenue Market Share by Type (2021-2032)
- 6.3 Global Endostatin Protein Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Endostatin Protein Sales by Application (2021-2032)
- 7.1.1 Global Endostatin Protein Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Endostatin Protein Sales Market Share by Application (2021-2032)
- 7.2 Global Endostatin Protein Revenue by Application (2021-2032)
- 7.2.1 Global Endostatin Protein Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Endostatin Protein Revenue Market Share by Application (2021-2032)
- 7.3 Global Endostatin Protein Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Endostatin Protein Value Chain Analysis
- 8.1.1 Endostatin Protein Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Endostatin Protein Production Mode & Process
- 8.2 Endostatin Protein Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Endostatin Protein Distributors
- 8.2.3 Endostatin Protein Customers
9 Global Endostatin Protein Analyzing Market Dynamics
- 9.1 Endostatin Protein Industry Trends
- 9.2 Endostatin Protein Industry Drivers
- 9.3 Endostatin Protein Industry Opportunities and Challenges
- 9.4 Endostatin Protein Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst